1802181-20-9 , HM61713, BI 1482694 , BI 1482694 , HM61713
Olmutinib (HM61713, BI 1482694) is an orally available small molecule, a mutant-selective inhibitor of epidermal growth factor receptor (EGFR) with potential antineoplastic activity. Olmutinib binds to and inhibits mutant forms of EGFR, thereby leading to cell death of EGFR-expressing tumor cells. As this agent is selective towards mutant forms of EGFR, its toxicity profile may be reduced as compared to non-selective EGFR inhibitors which also inhibit the EGFR wild-type form.
Molecular Weight:
486.59
Purity:
97.46%
CAS Number:
[1353550-13-6]
Formula:
C26H26N6O2S
Target:
BTK|||EGFR
T6918
* VAT and and shipping costs not included. Errors and price changes excepted